Parvovirus B19 DNA detectable in hearts of patients with dilated cardiomyopathy, but absent or inactive in blood
Abstract Aims Parvovirus B19 (B19V) is often assumed to be a cause of dilated cardiomyopathy (DCM), based on the quantification of B19V DNA in endomyocardial biopsies (EMB). Whether the presence of B19V DNA correlates with active infection is still debated. Application of the enzyme endonuclease to...
Main Authors: | Anne Russcher, Job Verdonschot, Marijke W.A. Molenaar‐de Backer, Stephane R.B. Heymans, Aloys C.M. Kroes, Hans L. Zaaijer |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-08-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.13341 |
Similar Items
-
Ultrastructural Changes in Mitochondria in Patients with Dilated Cardiomyopathy and Parvovirus B19 Detected in Heart Tissue without Myocarditis
by: Agnieszka Pawlak, et al.
Published: (2022-01-01) -
Systematic Review of PCR Proof of Parvovirus B19 Genomes in Endomyocardial Biopsies of Patients Presenting with Myocarditis or Dilated Cardiomyopathy
by: Angelos G. Rigopoulos, et al.
Published: (2019-06-01) -
Etymologia: Parvovirus
by: Eduardo K.U.N. Fonseca
Published: (2018-02-01) -
Nucleoside Analogue Reverse Transcriptase Inhibitors Improve Clinical Outcome in Transcriptional Active Human Parvovirus B19-Positive Patients
by: Heinz-Peter Schultheiss, et al.
Published: (2021-04-01) -
Lower Incidence of Parvovirus-B19 Infections in Dutch Blood Donors during SARS-CoV-2 Pandemic
by: M. W. Molenaar-de Backer, et al.
Published: (2021-10-01)